144 related articles for article (PubMed ID: 38153397)
1. Radiotherapy dose escalation for high-risk meningiomas after subtotal resection.
Raleigh DR
Neuro Oncol; 2024 Apr; 26(4):713-714. PubMed ID: 38153397
[No Abstract] [Full Text] [Related]
2. Early adjuvant radiotherapy in the treatment of atypical meningioma.
Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GM; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M
J Clin Neurosci; 2016 Jun; 28():87-92. PubMed ID: 26775147
[TBL] [Abstract][Full Text] [Related]
3. Role of adjuvant radiotherapy in atypical (WHO grade II) and anaplastic (WHO grade III) meningiomas: a systematic review.
Delgado-López PD; Corrales-García EM
Clin Transl Oncol; 2021 Feb; 23(2):205-221. PubMed ID: 32651886
[TBL] [Abstract][Full Text] [Related]
4. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
Rydzewski NR; Lesniak MS; Chandler JP; Kalapurakal JA; Pollom E; Tate MC; Bloch O; Kruser T; Dalal P; Sachdev S
Cancer; 2018 Feb; 124(4):734-742. PubMed ID: 29131312
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review.
Kaur G; Sayegh ET; Larson A; Bloch O; Madden M; Sun MZ; Barani IJ; James CD; Parsa AT
Neuro Oncol; 2014 May; 16(5):628-36. PubMed ID: 24696499
[TBL] [Abstract][Full Text] [Related]
6. Effect of adjuvant radiotherapy after subtotal resection for WHO grade I meningioma: a propensity score matching analysis of the Brain Tumor Registry of Japan.
Oya S; Ikawa F; Ichihara N; Wanibuchi M; Akiyama Y; Nakatomi H; Mikuni N; Narita Y
J Neurooncol; 2021 Jun; 153(2):351-360. PubMed ID: 34002302
[TBL] [Abstract][Full Text] [Related]
7. In Reply: Adjuvant Radiotherapy Versus Watchful Waiting for World Health Organization Grade II Atypical Meningioma: A Single-Institution Experience.
Bray DP; Quillin JW; Press RH; Yang Y; Chen Z; Eaton BR; Olson JJ
Neurosurgery; 2021 Oct; 89(5):E279-E280. PubMed ID: 34382655
[No Abstract] [Full Text] [Related]
8. Letter: Adjuvant Radiotherapy Versus Watchful Waiting for World Health Organization Grade II Atypical Meningioma: A Single-Institution Experience.
Della Pepa GM; Chiesa S; Rapisarda A; D'Alessandris QG; Bonaventura RD; Pallini R; Olivi A
Neurosurgery; 2021 Oct; 89(5):E277-E278. PubMed ID: 34382646
[No Abstract] [Full Text] [Related]
9. Commentary: Adjuvant Radiotherapy Versus Watchful Waiting for World Health Organization Grade II Atypical Meningioma: A Single-Institution Experience.
Chicoine MR; Kim AH
Neurosurgery; 2021 Apr; 88(5):E443-E444. PubMed ID: 33611601
[No Abstract] [Full Text] [Related]
10. In Reply: Commentary: Adjuvant Radiotherapy Versus Watchful Waiting for World Health Organization Grade II Atypical Meningioma: A Single-Institution Experience.
Chicoine MR; Kim AH
Neurosurgery; 2021 Aug; 89(3):E176-E177. PubMed ID: 34098571
[No Abstract] [Full Text] [Related]
11. Letter: Commentary: Adjuvant Radiotherapy Versus Watchful Waiting for World Health Organization Grade II Atypical Meningioma: A Single-Institution Experience.
Bray DP; Quillin JW; Press RH; Yang Y; Chen Z; Eaton BR; Olson JJ
Neurosurgery; 2021 Aug; 89(3):E174-E175. PubMed ID: 34089326
[No Abstract] [Full Text] [Related]
12. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.
Zhu H; Bi WL; Aizer A; Hua L; Tian M; Den J; Tang H; Chen H; Wang Y; Mao Y; Dunn IF; Xie Q; Gong Y
Cancer Med; 2019 Jan; 8(1):13-20. PubMed ID: 30680963
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy as an adjuvant in the management of intracranial meningiomas: are we practising evidence-based medicine?
Marcus HJ; Price SJ; Wilby M; Santarius T; Kirollos RW
Br J Neurosurg; 2008 Aug; 22(4):520-8. PubMed ID: 18803079
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas.
Unterberger A; Nguyen T; Duong C; Kondajji A; Kulinich D; Yang I
J Neurooncol; 2021 Apr; 152(2):205-216. PubMed ID: 33635510
[TBL] [Abstract][Full Text] [Related]
16. Atypical and malignant meningiomas: Considerations for treatment and efficacy of radiotherapy.
Cain SA; Smoll NR; Van Heerden J; Tsui A; Drummond KJ
J Clin Neurosci; 2015 Nov; 22(11):1742-8. PubMed ID: 26213286
[TBL] [Abstract][Full Text] [Related]
17. Conventional radiation therapy for skull base meningiomas.
Goldsmith BJ; Larson DA
Neurosurg Clin N Am; 2000 Oct; 11(4):605-15. PubMed ID: 11082171
[No Abstract] [Full Text] [Related]
18. Efficacy and toxicity of particle radiotherapy in WHO grade II and grade III meningiomas: a systematic review.
Wu A; Jin MC; Meola A; Wong HN; Chang SD
Neurosurg Focus; 2019 Jun; 46(6):E12. PubMed ID: 31153145
[TBL] [Abstract][Full Text] [Related]
19. Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis.
Stessin AM; Schwartz A; Judanin G; Pannullo SC; Boockvar JA; Schwartz TH; Stieg PE; Wernicke AG
J Neurosurg; 2012 Oct; 117(4):669-75. PubMed ID: 22900840
[TBL] [Abstract][Full Text] [Related]
20. Early or late radiotherapy following gross or subtotal resection for atypical meningiomas: Clinical outcomes and local control.
Dohm A; McTyre ER; Chan MD; Fan C; Isom S; Bourland JD; Mott RT; Cramer CK; Tatter SB; Laxton AW
J Clin Neurosci; 2017 Dec; 46():90-98. PubMed ID: 28917587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
